Trade this ETF at your broker
Index | MSCI ACWI IMI Genomic Innovation Select ESG Screened 100 |
Investment focus | Aktien, Welt, Gesundheitswesen, Sozial/Nachhaltig |
Fund size | EUR 3 m |
Total expense ratio | 0,30% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | Ja |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in EUR) | 16,67% |
Inception/ Listing Date | 12. Juli 2022 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Irland |
Fund Provider | Xtrackers |
Fund Structure | Company With Variable Capital (SICAV) |
UCITS compliance | Yes |
Administrator | State Street Custodial Services (Ireland) Limited |
Investment Advisor | DWS Investments UK Limited |
Custodian Bank | State Street Custodial Services (Ireland) Limited |
Revision Company | Pricewaterhouse Coopers |
Fiscal Year End | 31. Dezember |
Swiss representative | DWS CH AG |
Swiss paying agent | Deutsche Bank (Suisse) SA |
Tax data | Bundesanzeiger | |
Germany | 30% Teilfreistellung | |
Switzerland | ESTV Reporting | |
Austria | Meldefonds | |
UK | UK Reporting |
Indextype | - |
Swap counterparty | - |
Collateral manager | |
Securities lending | Yes |
Securities lending counterparty |
Vertex Pharmaceuticals, Inc. | 4,92% |
Roche Holding AG | 4,74% |
Abbott Laboratories | 4,68% |
ICON plc | 4,55% |
Bristol Myers Squibb Co. | 4,53% |
Lonza Group AG | 4,47% |
Danaher Corp. | 4,36% |
Thermo Fisher Scientific, Inc. | 4,30% |
Agilent Technologies | 3,92% |
Illumina, Inc. | 3,90% |
USA | 76,14% |
Schweiz | 10,48% |
Irland | 4,55% |
China | 2,35% |
Sonstige | 6,48% |
Gesundheitswesen | 95,36% |
Sonstige | 4,64% |
Broker | Rating | Ordergebühr | ETF Sparplan | |
---|---|---|---|---|
0,00€ | 2536 | View offer* | ||
1,00€ | 2252 | View offer* | ||
0,00€ | 1408 | View offer* | ||
0,00€ | 898 | View offer* | ||
0,00€ | 785 | View offer* |
YTD | +6,37% |
1 maand | +1,31% |
3 maanden | +3,70% |
6 maanden | +7,53% |
1 jaar | +4,92% |
3 jaar | - |
5 jaar | - |
Since inception | -12,31% |
2023 | -7,06% |
2022 | - |
2021 | - |
2020 | - |
Volatiliteit 1 jaar | 16,50% |
Volatiliteit 3 jaar | - |
Volatiliteit 5 jaar | - |
Rendement/Risico 1 jaar | 0,24 |
Rendement/Risico 3 jaar | - |
Rendement/Risico 5 jaar | - |
Maximaal waardedaling 1 jaar | -14,23% |
Maximaal waardedaling 3 jaar | - |
Maximaal waardedaling 5 jaar | - |
Maximaal waardedaling sinds aanvang | -30,08% |
Beursnotering | Handelsvaluta | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | XGEN | - - | - - | - |
Borsa Italiana | EUR | XGEN | XGEN IM XGENEUIV | XGEN.MI XGENEURINAV=SOLA | |
London Stock Exchange | USD | XGEN | XGEN LN XGENUSIV | XGEN.L XGENUSDINAV=SOLA | |
London Stock Exchange | GBP | XGES | XGES LN XGENCHIV | XGES.L XGENCHFINAV=SOLA | |
SIX Swiss Exchange | CHF | XGEN | XGEN SW XGENGBIV | XGEN.S XGENGBPINAV=SOLA | |
XETRA | EUR | XGEN | XGEN GR | XGEN.DE |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Healthcare Innovation UCITS ETF | 1,025 | 0.40% p.a. | Accumulating | Sampling |
VanEck Genomics and Healthcare Innovators UCITS ETF A | 6 | 0.35% p.a. | Accumulating | Full replication |